院内感染対策の世界市場レポート 2025年

院内感染対策市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.5%で444億2,000万米ドルに成長します。予測期間の成長は、多剤耐性病原体の増加、パンデミックへの備え、サーベイランスとモニタリングの強化、抗菌薬スチュワードシッププログラム、国際協力に起因すると考えられます。予測期間中の主な動向としては、リアルタイムロケーションシステム（RTLS）の採用、サーベイランスのための人工知能（AI）の統合、シングルユースおよび使い捨て機器へのシフト、スタッフのトレーニングと教育の重視、消毒技術の利用拡大などが挙げられます。

院内感染対策市場は、COVID-19症例の急増が成長の原動力になると予測されます。SARS-CoV-2ウイルスによって引き起こされたCOVID-19は、個人の衛生や医療用品の生産を重視し、感染制御製品やサービスの需要増につながっています。世界保健機関（WHO）によると、2022年8月8日現在、世界のCOVID-19感染者数は5億8,160万人に達し、パンデミックの進行による市場の拡大を裏付けています。

ヘルスケア支出の増加が院内感染対策市場の成長を牽引すると予想されます。ヘルスケア支出は、個人レベル、地域レベル、国レベル、世界レベルのいずれであっても、定義された時間枠内のヘルスケアサービス、製品、活動に対する総支出を包含します。ヘルスケア支出の増加に伴い、病院や医療施設は高度な感染予防技術の導入により多くのリソースを割り当てる可能性が高いです。これには、高度な消毒システム、スマート・モニタリング・デバイス、感染対策全体を強化するその他の技術などの革新的ソリューションが含まれます。例えば、2024年5月、英国の政府機関である国家統計局は、2022年から2023年にかけての総ヘルスケア支出が名目ベースで5.6％増加すると報告した（2022年の伸びはわずか0.9％）。その結果、ヘルスケア支出の増加は、今後の院内感染対策市場の成長を促進する態勢を整えています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界院内感染対策PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の院内感染対策市場：成長率分析
• 世界の院内感染対策市場の実績：規模と成長, 2019-2024
• 世界の院内感染対策市場の予測：規模と成長, 2024-2029, 2034F
• 世界院内感染対策総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の院内感染対策市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 滅菌器
• 消毒剤
• 内視鏡再処理装置
• 微生物検査機器
• 消耗品
• 消毒剤
• 感染予防および監視ソフトウェア
• その他の製品
• 世界の院内感染対策市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 表現型分析法
• 遺伝子型法
• 世界の院内感染対策市場病気別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 院内肺炎
• 血流感染症
• 手術部位感染
• 胃腸感染症
• 尿路感染症
• その他の病気
• 世界の院内感染対策市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病気の検査
• 薬剤耐性検査
• 世界の院内感染対策市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 集中治療室
• 外来手術
• 診断センター
• 老人ホーム
• 産科センター
• その他のエンドユーザー
• 世界の院内感染対策市場滅菌器の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 蒸気滅菌器
• エチレンオキシド殺菌装置
• 過酸化水素殺菌装置
• 世界の院内感染対策市場、消毒剤の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 洗浄消毒機
• 自動消毒装置
• 世界の院内感染対策市場内視鏡リプロセッサーの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高水準消毒再処理装置
• 自動内視鏡再処理装置
• 世界の院内感染対策市場微生物検査機器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 文化システム
• 迅速微生物検査システム
• 世界の院内感染対策市場消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 滅菌ラップ
• フィルター
• 個人用保護具（PPE）
• 世界の院内感染対策市場、消毒剤の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルコール系消毒剤
• 塩素系消毒剤
• 第四級アンモニウム化合物
• 世界の院内感染対策市場、感染予防および監視ソフトウェアの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 監視ソフトウェアソリューション
• データ管理ソフトウェア
• 世界の院内感染対策市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 清掃用具
• 空気清浄システム

第7章 地域別・国別分析

• 世界の院内感染対策市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の院内感染対策市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 院内感染対策市場：競合情勢
• 院内感染対策市場：企業プロファイル
  • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • P&G Professional Overview, Products and Services, Strategy and Financial Analysis
  • Honeywell International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • MMM Group Overview, Products and Services, Strategy and Financial Analysis
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton Dickinson and Company
• Reckitt Benckiser Group plc.
• Ecolab Inc
• Olympus Corporation
• Miele Group
• Biomerieux SA
• Getinge AB
• Halyard Health Inc.
• Ansell Limited
• Sotera Health LLC
• Contec Inc.
• Cantel Medical Corp.
• Belimed AG
• Nanosonics Limited
• Advanced Sterilization Products Services Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 院内感染対策市場2029：新たな機会を提供する国
• 院内感染対策市場2029：新たな機会を提供するセグメント
• 院内感染対策市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hospital-acquired infections, acquired during hospital care and absent before admission, are managed through hospital-acquired infection control, employing cleaning, sterilization, and disinfection methods to reduce or eliminate transmission. These infections may stem from cross-contamination involving equipment surfaces, patient skin, and healthcare staff. The goal of hospital-acquired infection control is to curb the spread of illnesses.

The primary types of products in hospital-acquired infection control encompass sterilizers, disinfectors, endoscope reprocessors, microbial testing instruments, reagents, consumables, disinfectants, infection prevention and surveillance software, and others. Sterilizers, machines designed to thoroughly cleanse and eliminate bacteria, are employed to kill germs on surfaces or in fluids, preventing disease transmission. Various technologies, including phenotypic and genotypic methods, address diseases such as hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections, and others. Applications range from disease testing to drug-resistance testing, with end users including hospitals, ICUs, ambulatory surgical and diagnostic centers, nursing homes, maternity centers, and others.

The hospital-acquired infection control market research report is one of a series of new reports from The Business Research Company that provides hospital-acquired infection control market statistics, including hospital-acquired infection control industry global market size, regional shares, competitors with a hospital-acquired infection control market share, detailed hospital-acquired infection control market segments, market trends and opportunities, and any further data you may need to thrive in the hospital-acquired infection control industry. This hospital-acquired infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hospital-acquired infection control market size has grown steadily in recent years. It will grow from $34.59 billion in 2024 to $35.86 billion in 2025 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to increasing antibiotic resistance, growing awareness, stringent regulations, globalization of infectious diseases, patient safety initiatives.

The hospital-acquired infection control market size is expected to see strong growth in the next few years. It will grow to $44.42 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise of multidrug-resistant pathogens, pandemic preparedness, increased surveillance and monitoring, antimicrobial stewardship programs, international collaboration. Major trends in the forecast period include adoption of real-time location systems (RTLS), integration of artificial intelligence (AI) for surveillance, shift towards single-use and disposable devices, emphasis on staff training and education, increased utilization of disinfection technologies.

The hospital-acquired infection control market is anticipated to experience growth driven by the surge in COVID-19 cases. COVID-19, caused by the SARS-CoV-2 virus, has led to an increased demand for infection control products and services, emphasizing personal hygiene and the production of medical supplies. As of August 8, 2022, global COVID-19 cases reached 581.6 million, according to the World Health Organization, underscoring the market's expansion due to the ongoing pandemic.

Rising healthcare expenditures are expected to drive the growth of the hospital-acquired infection control market. Healthcare expenditures encompass the total spending on healthcare services, products, and activities within a defined timeframe, whether at the individual, community, national, or global level. As healthcare spending increases, hospitals and healthcare facilities are likely to allocate more resources toward adopting advanced infection prevention technologies. This includes innovative solutions such as advanced disinfection systems, smart monitoring devices, and other technologies that enhance overall infection control measures. For example, in May 2024, the Office for National Statistics, a UK-based government agency, reported a 5.6% increase in total healthcare expenditure in nominal terms between 2022 and 2023, compared to a mere 0.9% growth in 2022. Consequently, the rising healthcare expenditure is poised to fuel the growth of the hospital-acquired infection control market in the future.

Leading companies in the hospital-acquired infection control market are concentrating on creating new technological solutions, such as AI systems aimed at the early identification of sepsis to improve patient outcomes through prompt diagnosis and treatment. An AI system designed to assist in recognizing sepsis refers to advanced technological solutions that employ artificial intelligence and machine learning algorithms to detect initial signs of sepsis in patients. For example, in April 2024, Prenosis Inc., a US-based medical clinic, obtained FDA marketing authorization for the Sepsis ImmunoScore, the first AI-driven system created to predict sepsis, a potentially life-threatening condition that can result in serious complications. This innovative tool enhances early detection by analyzing real-time data, enabling healthcare professionals to respond more quickly and effectively. The integration of AI is intended to support medical staff in their decision-making processes rather than replace them, ultimately leading to improved patient outcomes and reduced healthcare costs.

Major companies in the hospital-acquired infection control market are obtaining regulatory approvals to launch innovative products and technologies aimed at decreasing the incidence of infections within healthcare environments. Regulatory approvals refer to the authorizations granted by government agencies or regulatory bodies that permit a company to market and sell its products or services. For example, in May 2023, Innoviva Specialty Therapeutics, a US-based biopharmaceutical company, received approval for the new treatment Xacduro (sulbactam and durlobactam), which is designed for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by specific strains of the Acinetobacter baumannii-calcoaceticus complex. This approval addresses the growing problem of antimicrobial resistance, particularly concerning Acinetobacter species. Xacduro combines sulbactam, which is effective against A. Common side effects may include abnormalities in liver function tests. The drug was granted several designations to expedite its development and review, underscoring its importance in treating severe bacterial infections in healthcare settings.

In August 2024, MicroCare, LLC, a US-based company that develops and manufactures cleaning and disinfecting products for the medical sector, acquired ICT Infection Control Technologies for an undisclosed amount. This acquisition allows MicroCare to enhance its healthcare portfolio by integrating ICT's specialized infection control solutions into its existing range of cleaning and lubrication products. This strategic move aims to strengthen MicroCare's position in the rapidly expanding medical infection prevention market, thereby improving the safety and effectiveness of cleaning solutions for healthcare facilities. ICT Infection Control Technologies is a US-based company that focuses on manufacturing infection control chemistries primarily for the dental and medical sectors.

Major companies operating in the hospital-acquired infection control market include Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schulke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.

North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hospital-acquired infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hospital-acquired infection control market includes revenues earned by entities by heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, other sterilization equipment, contract sterilization services, sterilization consumables and accessories, disinfectants, and disinfectors equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hospital-Acquired Infection Control Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hospital-acquired infection control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hospital-acquired infection control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hospital-acquired infection control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Sterilizers; Disinfectors; Endoscope Reprocessors; Microbial Testing Instruments; Consumables; Disinfectants; Infection Prevention And Surveillance Software; Other Products
• 2) By Technology: Phenotypic Methods; Genotypic Methods
• 3) By Diseases: Hospital Acquired Pneumonia; Bloodstream Infections; Surgical Site Infections; Gastrointestinal Infections; Urinary Tract Infection; Other Diseases
• 4) By Application: Disease Testing; Drug-Resistance Testing
• 5) By End User: Hospitals; ICUs; Ambulatory Surgical; Diagnostic Centers; Nursing Homes; Maternity Centers; Other End Users
• Subsegments:
• 1) By Sterilizers: Steam Sterilizers; Ethylene Oxide Sterilizers; Hydrogen Peroxide Sterilizers
• 2) By Disinfectors: Washer Disinfectors; Automated Disinfectors
• 3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors; Automated Endoscope Reprocessors
• 4) By Microbial Testing Instruments: Culture Systems; Rapid Microbial Testing Systems
• 5) By Consumables: Sterilization Wraps; Filters; Personal Protective Equipment (PPE)
• 6) By Disinfectants: Alcohol-based Disinfectants; Chlorine-based Disinfectants; Quaternary Ammonium Compounds
• 7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions; Data Management Software
• 8) By Other Products: Cleaning Equipment; Air Purification Systems
• Companies Mentioned: Johnson and Johnson; P&G Professional; Honeywell International Inc.; MMM Group; 3M Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hospital-Acquired Infection Control Market Characteristics

3. Hospital-Acquired Infection Control Market Trends And Strategies

4. Hospital-Acquired Infection Control Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hospital-Acquired Infection Control Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hospital-Acquired Infection Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hospital-Acquired Infection Control Market Growth Rate Analysis
• 5.4. Global Hospital-Acquired Infection Control Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hospital-Acquired Infection Control Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hospital-Acquired Infection Control Total Addressable Market (TAM)

6. Hospital-Acquired Infection Control Market Segmentation

• 6.1. Global Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sterilizers
• Disinfectors
• Endoscope Reprocessors
• Microbial Testing Instruments
• Consumables
• Disinfectants
• Infection Prevention And Surveillance Software
• Other Products
• 6.2. Global Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phenotypic Methods
• Genotypic Methods
• 6.3. Global Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infection
• Other Diseases
• 6.4. Global Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease Testing
• Drug-Resistance Testing
• 6.5. Global Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• ICUs
• Ambulatory Surgical
• Diagnostic Centers
• Nursing Homes
• Maternity Centers
• Other End Users
• 6.6. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Sterilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Steam Sterilizers
• Ethylene Oxide Sterilizers
• Hydrogen Peroxide Sterilizers
• 6.7. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Disinfectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Washer Disinfectors
• Automated Disinfectors
• 6.8. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Endoscope Reprocessors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Level Disinfection Reprocessors
• Automated Endoscope Reprocessors
• 6.9. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Microbial Testing Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Culture Systems
• Rapid Microbial Testing Systems
• 6.10. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sterilization Wraps
• Filters
• Personal Protective Equipment (PPE)
• 6.11. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Disinfectants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alcohol-based Disinfectants
• Chlorine-based Disinfectants
• Quaternary Ammonium Compounds
• 6.12. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Infection Prevention And Surveillance Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surveillance Software Solutions
• Data Management Software
• 6.13. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cleaning Equipment
• Air Purification Systems

7. Hospital-Acquired Infection Control Market Regional And Country Analysis

• 7.1. Global Hospital-Acquired Infection Control Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hospital-Acquired Infection Control Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hospital-Acquired Infection Control Market

• 8.1. Asia-Pacific Hospital-Acquired Infection Control Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hospital-Acquired Infection Control Market

• 9.1. China Hospital-Acquired Infection Control Market Overview
• 9.2. China Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hospital-Acquired Infection Control Market

• 10.1. India Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hospital-Acquired Infection Control Market

• 11.1. Japan Hospital-Acquired Infection Control Market Overview
• 11.2. Japan Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hospital-Acquired Infection Control Market

• 12.1. Australia Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hospital-Acquired Infection Control Market

• 13.1. Indonesia Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hospital-Acquired Infection Control Market

• 14.1. South Korea Hospital-Acquired Infection Control Market Overview
• 14.2. South Korea Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hospital-Acquired Infection Control Market

• 15.1. Western Europe Hospital-Acquired Infection Control Market Overview
• 15.2. Western Europe Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hospital-Acquired Infection Control Market

• 16.1. UK Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hospital-Acquired Infection Control Market

• 17.1. Germany Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hospital-Acquired Infection Control Market

• 18.1. France Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hospital-Acquired Infection Control Market

• 19.1. Italy Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hospital-Acquired Infection Control Market

• 20.1. Spain Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hospital-Acquired Infection Control Market

• 21.1. Eastern Europe Hospital-Acquired Infection Control Market Overview
• 21.2. Eastern Europe Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hospital-Acquired Infection Control Market

• 22.1. Russia Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hospital-Acquired Infection Control Market

• 23.1. North America Hospital-Acquired Infection Control Market Overview
• 23.2. North America Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hospital-Acquired Infection Control Market

• 24.1. USA Hospital-Acquired Infection Control Market Overview
• 24.2. USA Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hospital-Acquired Infection Control Market

• 25.1. Canada Hospital-Acquired Infection Control Market Overview
• 25.2. Canada Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hospital-Acquired Infection Control Market

• 26.1. South America Hospital-Acquired Infection Control Market Overview
• 26.2. South America Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hospital-Acquired Infection Control Market

• 27.1. Brazil Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hospital-Acquired Infection Control Market

• 28.1. Middle East Hospital-Acquired Infection Control Market Overview
• 28.2. Middle East Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hospital-Acquired Infection Control Market

• 29.1. Africa Hospital-Acquired Infection Control Market Overview
• 29.2. Africa Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hospital-Acquired Infection Control Market Competitive Landscape And Company Profiles

• 30.1. Hospital-Acquired Infection Control Market Competitive Landscape
• 30.2. Hospital-Acquired Infection Control Market Company Profiles
  • 30.2.1. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. P&G Professional Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Honeywell International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. MMM Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis

31. Hospital-Acquired Infection Control Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. Reckitt Benckiser Group plc.
• 31.3. Ecolab Inc
• 31.4. Olympus Corporation
• 31.5. Miele Group
• 31.6. Biomerieux SA
• 31.7. Getinge AB
• 31.8. Halyard Health Inc.
• 31.9. Ansell Limited
• 31.10. Sotera Health LLC
• 31.11. Contec Inc.
• 31.12. Cantel Medical Corp.
• 31.13. Belimed AG
• 31.14. Nanosonics Limited
• 31.15. Advanced Sterilization Products Services Inc

32. Global Hospital-Acquired Infection Control Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hospital-Acquired Infection Control Market

34. Recent Developments In The Hospital-Acquired Infection Control Market

35. Hospital-Acquired Infection Control Market High Potential Countries, Segments and Strategies

• 35.1 Hospital-Acquired Infection Control Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hospital-Acquired Infection Control Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hospital-Acquired Infection Control Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer